Most pituitary tumors arise from spontaneous genetic changes in a single pituitary cell that cause it to multiply out of control. These tumors, called pituitary adenomas, are overwhelmingly benign and remarkably common: they show up in about 14% of autopsies and 23% of brain MRI scans done for unrelated reasons. Despite how often they occur, no single cause explains every case. Instead, a combination of gene mutations, inherited conditions, and chemical changes to DNA can each set the stage for a pituitary cell to start growing when it shouldn’t.
Spontaneous Gene Mutations
The vast majority of pituitary tumors are “sporadic,” meaning they aren’t inherited. They develop when a mutation happens by chance in a pituitary cell during a person’s lifetime. Several specific genes have been identified.
The most well-known is a gene called GNAS, which helps regulate a signaling system inside cells that uses a molecule called cAMP. When GNAS mutates, this signaling gets stuck in the “on” position, telling the cell to keep growing and producing hormones. GNAS mutations appear in up to 40% of growth-hormone-secreting pituitary tumors, making it the single most common genetic change found in that tumor type.
For tumors that overproduce the stress hormone ACTH (the kind that causes Cushing’s disease), a different gene called USP8 is the main culprit. Roughly 32% of these tumors carry a USP8 mutation, with some studies finding rates as high as 62%. Among ACTH-producing tumors that don’t have a USP8 mutation, about 23% have mutations in a gene called USP48 and 16% carry changes in BRAF, a gene more commonly associated with skin cancers and thyroid cancers.
A small subset of aggressive, invasive pituitary tumors carry mutations in a pathway called PI3K. These mutations were found in about 9% of invasive tumors but in none of the non-invasive ones studied, suggesting this particular change may play a role in making tumors more likely to grow into surrounding tissue.
How Cell Signaling Goes Wrong
To understand why these mutations matter, it helps to know how pituitary cells normally receive instructions. Cells in the pituitary gland rely heavily on a communication system called the G-protein-coupled receptor pathway. Hormones from the brain dock onto receptors on the outside of pituitary cells, which triggers a chain reaction inside the cell. A key player in that chain is cAMP, a small molecule that acts like an internal messenger, telling the cell to grow, divide, or release hormones.
When mutations hit genes that control this pathway, the messenger system can get locked into a permanently active state. The cell behaves as though it’s constantly receiving a “grow and secrete” signal, even when no such signal is coming from the brain. Over time, that single malfunctioning cell multiplies into a tumor. Other signaling routes, including ones involved in cell survival and stem cell regulation, have also been linked to pituitary tumor formation, which helps explain why these tumors can develop through many different genetic starting points.
Inherited Conditions
About 5% of pituitary tumors run in families, linked to inherited gene mutations that a person is born with. Several distinct syndromes are responsible.
Multiple Endocrine Neoplasia Type 1 (MEN1)
MEN1 is caused by an inherited loss of the MEN1 gene, a tumor suppressor. People with this condition develop tumors in multiple hormone-producing glands, including the pituitary, the parathyroid glands in the neck, and the pancreas. Pituitary tumors in MEN1 can produce various hormones and tend to appear alongside these other endocrine tumors.
Carney Complex
About half of people with Carney complex carry mutations in a gene called PRKAR1A, which disrupts a protein involved in the same cAMP signaling system that GNAS affects. Pituitary tumors in Carney complex almost exclusively produce growth hormone, sometimes alongside prolactin. The pituitary gland in these patients often shows areas of overgrowth (hyperplasia) that appear to precede actual tumor formation, suggesting the gland gradually shifts from overactive to truly tumorous. Most patients who develop acromegaly (the condition caused by excess growth hormone) from Carney complex have larger tumors, and some have multiple tumors within the same gland.
McCune-Albright Syndrome
This condition is caused by mutations in the same GNAS gene involved in sporadic tumors, but in McCune-Albright the mutation occurs very early in embryonic development, so it affects many tissues throughout the body. Like Carney complex, pituitary involvement typically starts with hormone-producing cell overgrowth before progressing to tumor formation.
Familial Isolated Pituitary Adenoma (FIPA)
Some families develop pituitary tumors without any of the other features of MEN1 or Carney complex. In many of these families, the cause is an inherited mutation in the AIP gene, which normally acts as a tumor suppressor in pituitary cells. AIP-related pituitary tumors tend to appear young, with a median age of diagnosis of just 23 years, typically in the second or third decade of life. These tumors most often produce growth hormone or prolactin and can be more aggressive than their sporadic counterparts.
Epigenetic Changes
Not all pituitary tumors are caused by mutations that alter the DNA code itself. Some arise through “epigenetic” changes, which are chemical modifications that sit on top of DNA and control whether a gene gets switched on or off. The gene’s code stays intact, but it gets silenced, as if someone taped over the play button.
The most studied epigenetic mechanism in pituitary tumors is DNA methylation, where small chemical tags attach to a gene’s promoter region and prevent the cell from reading it. This matters most when the silenced gene is a tumor suppressor, one whose job is to slow cell growth or trigger damaged cells to self-destruct. A systematic review identified 16 tumor suppressor genes silenced by methylation in pituitary tumors, with 11 of them involved in controlling cell division or programmed cell death.
One gene called CDKN2A, which produces a protein that puts the brakes on cell division, is methylated and silenced in up to 90% of sporadic pituitary tumors. Another, RB1 (the same gene involved in the childhood eye cancer retinoblastoma), is also frequently silenced through methylation in sporadic cases. When these brake-pedal genes go quiet, cells lose a critical checkpoint and can proliferate unchecked. Additional tumor suppressors involved in triggering cell death are silenced by methylation in more than half of pituitary tumors studied.
Beyond methylation, modifications to the proteins that DNA wraps around (called histones) can also drive tumor growth. In lab studies of pituitary cells, certain histone changes repressed protective molecules and boosted the activity of known growth-promoting genes, leading to increased cell proliferation.
Who Gets Pituitary Tumors
Pituitary tumors become more common with age, but the pattern differs between men and women. Women are diagnosed more frequently than men during early adulthood, up to about age 30. After that, the trend reverses and men are diagnosed at higher rates in later life. The overall difference between sexes isn’t statistically significant when you look at all ages combined, but the age-by-sex interaction is striking. One reason for the higher detection rate in younger women is that hormone-producing tumors (especially prolactinomas) cause noticeable menstrual changes that prompt earlier medical evaluation.
Environmental and Occupational Factors
Compared to genetic and epigenetic causes, environmental risk factors for pituitary tumors specifically are not well established. Direct evidence linking chemical exposures to pituitary tumors remains limited, and much of what researchers know is borrowed from studies on brain tumors more broadly. Occupations in fields like electronics manufacturing, oil refining, rubber production, farming, and the chemical and pharmaceutical industries have been associated with higher rates of central nervous system tumors overall. Suspected agents include benzene, other organic solvents, formaldehyde, vinyl chloride, and both ionizing and non-ionizing radiation.
More recently, some epidemiological studies have suggested air pollution may play a role in pituitary tumor development and could even increase the hormone-secreting activity of existing tumors. But this is still an emerging area of research, and no specific environmental exposure has been confirmed as a definitive cause of pituitary adenomas in the way that, say, asbestos is linked to mesothelioma. For the vast majority of people diagnosed with a pituitary tumor, the cause traces back to the spontaneous genetic or epigenetic changes described above rather than anything they were exposed to.